Therefore, increases of ATX levels and LPA local production in ARDS, ILD/IPF and COVID-19 can exacerbate numerous pathogenic responses in the lung, likely in co-ordination with other pathologic inflammatory and fibrotic factors. The gene discussed is ENPP2; the disease is COVID-19.